Blood Diseases Hospital


As the largest treatment center for blood diseases in China, Blood Diseases Hospital has a great deal of experience with rare illnesses and incurable conditions. It has developed internationally recognized protocols for the management of adult AML, childhood acute lymphoblastic leukemia (ALL), lymphoma multiple myeloma (MM), myelodysplastic syndrome (MDS), SAA, and idiopathic thrombocytopenic purpura (ITP). Blood Diseases Hospital provides medical services for patients throughout the country. An average of 148,000 patients were treated each year between 2011 and 2015. Blood Diseases Hospital was ranked as the best hospital for blood diseases for the past six years (2010 to 2015) by the Hospital Management Institute of Fudan University. 

Below are highlights of its clinical achievements: 

Adult AML: nearly 80% of cases achieved complete remission, with a 3-year overall survival rate of over 60%

Childhood ALL: standardization of diagnosis and treatment of childhood ALL in China with 98% of patients in complete remission and an 85% 5-year event free survival rate

MM: outlined practical guidelines for diagnosis and treatment of the disease in China and conducted systematic cytogenetic research

MDS: developed a new strategy for diagnosis, classification, prognosis, and treatment of MDS based on Chinese patient data

Hematopoietic stem cell transplantation (HSCT): carried out the first autologous HSCT in China, achieving a long-term survival rate of 70% in patients with acute leukemia; for allogeneic HSCT, a disease-free survival rate of more than 90% for AA patients was achieved

ITP: set up the first bleeding score for ITP patients in China and analyzed patient quality of life using the SF-36 health status questionnaire

Hematopathology: established a national reference laboratory operating within the Department of Pathology and Laboratory Medicine that collects more than 20,000 bone marrow biopsies annually, collaborates with more than 100 tertiary hospitals nationally for sample collection, and provides clinical laboratory testing all over China.

As a comprehensive center for hematology, Blood Diseases Hospital is committed to standardizing protocols for diagnosis and treatment, developing new technologies and methods for translational medicine in hematological malignancies, and advancing the field of hematology in China.